查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1732960

维生素 B2 市场 - 全球产业规模、份额、趋势、机会和预测（按销售管道、最终用途、地区和竞争细分，2020-2030 年）

Vitamin B2 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球维生素 B2 市值为 4.977 亿美元，预计到 2030 年将达到 7.2199 亿美元，复合年增长率为 4.20%。维生素 B2（核黄素）作为一种重要的水溶性营养素，支持能量产生和细胞功能，推动了注重健康的消费者群体对其的需求。人们对预防性医疗保健和营养的认识不断提高，促进了人们对富含维生素的补充剂和强化食品的摄取。核黄素被广泛认为可以促进新陈代谢、皮肤健康和神经功能。此外，它在动物饲料领域的使用对于改善牲畜的生长、免疫力和生殖健康起着至关重要的作用。新兴市场对优质肉类和乳製品的消费不断增长，进一步推动了对维生素强化饲料解决方案的需求。

市场概览
预测期 2026-2030
2024年市场规模 4.977亿美元
2030年市场规模 7.2199亿美元
2025-2030 年复合年增长率 4.20%
成长最快的领域 直接的
最大的市场 北美洲

关键市场驱动因素

製药业的成长

主要市场挑战

原料供应波动

主要市场趋势

对天然资源的偏好日益增加

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球维生素 B2 市场的影响

第五章：全球维生素B2市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按销售管道（直接、间接）
    • 依最终用途（动物饲料、药品和补充剂、食品和饮料强化剂、着色剂、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美维生素B2市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲维生素B2市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太维生素B2市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美维生素B2市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东与非洲维生素B2市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如有）
  • 最新动态

第 13 章：全球维生素 B2 市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • Hubei Guangji Pharmaceutical Co., Ltd
  • dsm-firmenich
  • BASF SE
  • Haijianuo Pharmaceutical Co., Ltd.
  • Zhejiang Shengda Bio-Pharm Co Ltd.
  • Shandong Hongda Biological Technology Co., Ltd.
  • Xinfa Pharmaceutical Co. Ltd
  • NB Group Co. Ltd

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 29219

The Global Vitamin B2 Market was valued at USD 497.70 million in 2024 and is projected to reach USD 721.99 million by 2030, growing at a CAGR of 4.20%. As a vital water-soluble nutrient, Vitamin B2 (riboflavin) supports energy production and cellular functions, driving its demand across health-conscious consumer segments. Increasing awareness around preventive healthcare and nutrition has encouraged the uptake of vitamin-enriched supplements and fortified foods. Riboflavin is widely recognized for promoting metabolism, skin health, and neurological function. Additionally, its use in the animal feed sector plays a crucial role in improving livestock growth, immunity, and reproductive health. The rising consumption of high-quality meat and dairy in emerging markets is further propelling demand for vitamin-enhanced feed solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 497.70 Million
Market Size 2030USD 721.99 Million
CAGR 2025-20304.20%
Fastest Growing SegmentDirect
Largest MarketNorth America

Key Market Drivers

Growth in Pharmaceutical Industry

The rapid expansion of the pharmaceutical industry has become a key driver for the global Vitamin B2 (riboflavin) market. With the pharmaceutical sector surpassing USD 1.6 trillion in revenue by 2023, riboflavin has gained prominence due to its critical functions in energy metabolism, antioxidant activity, and enzymatic reactions. Its inclusion in therapeutic products for addressing nutritional deficiencies and chronic fatigue highlights its medicinal significance. Notably, Eisai Co., Ltd.'s introduction of "Chocola BB Royal T" underscores this trend, utilizing activated vitamin B2 alongside royal jelly and taurine to boost energy metabolism. The growing prevalence of non-communicable diseases and malnutrition globally continues to bolster demand for riboflavin-based formulations.

Key Market Challenges

Volatility in Raw Material Supply

The Vitamin B2 market faces significant constraints due to unstable raw material supplies, which elevate production costs and disrupt availability. Key inputs such as fermentation substrates and chemical precursors often originate from geographically concentrated sources, making them susceptible to geopolitical instability, trade limitations, and environmental disruptions. Events like natural disasters, workforce shortages, and regulatory shifts in major supplier regions further aggravate supply chain uncertainties. These factors collectively strain manufacturers, threatening consistent product delivery and market stability.

Key Market Trends

Rising Preference for Natural Sources

A growing global shift toward natural, clean-label, and organic products is significantly influencing the Vitamin B2 market. Consumers are increasingly favoring riboflavin derived from microbial fermentation processes, which are viewed as safer and more environmentally sustainable compared to synthetic alternatives. The surge in organic food sales-from USD 18 billion in 2000 to over USD 136 billion by 2023-highlights this consumer transition. This trend is driven by heightened health awareness and scrutiny over artificial additives, prompting manufacturers to prioritize natural, non-GMO, and sustainably sourced ingredients.

Key Market Players

  • Hubei Guangji Pharmaceutical Co., Ltd
  • dsm-firmenich
  • BASF SE
  • Haijianuo Pharmaceutical Co., Ltd.
  • Zhejiang Shengda Bio-Pharm Co Ltd.
  • Shandong Hongda Biological Technology Co., Ltd.
  • Xinfa Pharmaceutical Co. Ltd
  • N.B Group Co. Ltd

Report Scope

In this report, the Global Vitamin B2 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B2 Market, By Sales Channel:

  • Direct
  • Indirect

Vitamin B2 Market, By End Use:

  • Animal feed
  • Pharmaceuticals & Supplements
  • Food & Beverage Fortification
  • Colorant
  • Others

Vitamin B2 Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B2 Market.

Available Customizations:

Global Vitamin B2 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Vitamin B2 Market

5. Global Vitamin B2 Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Animal feed, Pharmaceuticals & Supplements, Food & Beverage Fortification, Colorant, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Vitamin B2 Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vitamin B2 Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Vitamin B2 Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Vitamin B2 Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Vitamin B2 Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Vitamin B2 Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Vitamin B2 Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Vitamin B2 Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Vitamin B2 Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Vitamin B2 Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin B2 Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vitamin B2 Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Vitamin B2 Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Vitamin B2 Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Vitamin B2 Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Vitamin B2 Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Vitamin B2 Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Vitamin B2 Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Vitamin B2 Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Vitamin B2 Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Vitamin B2 Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Vitamin B2 Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Vitamin B2 Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Vitamin B2 Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vitamin B2 Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hubei Guangji Pharmaceutical Co., Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. dsm-firmenich
  • 15.3. BASF SE
  • 15.4. Haijianuo Pharmaceutical Co., Ltd.
  • 15.5. Zhejiang Shengda Bio-Pharm Co Ltd.
  • 15.6. Shandong Hongda Biological Technology Co., Ltd.
  • 15.7. Xinfa Pharmaceutical Co. Ltd
  • 15.8. N.B Group Co. Ltd

16. Strategic Recommendations

17. About Us & Disclaimer